NCT00375323View on ClinicalTrials.gov

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Hemophilia A

Interventions

DRUG

NovoSeven

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT00375323 - Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation | Biotech Hunter | Biotech Hunter